APM (Aptorum Group) Dividend Yield % : 0.00% (As of Dec. 11, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Dividend Yield %?

As of today (2024-12-11), the Trailing Annual Dividend Yield of Aptorum Group is 0.00%.

The historical rank and industry rank for Aptorum Group's Dividend Yield % or its related term are showing as below:

APM's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.41
* Ranked among companies with meaningful Dividend Yield % only.

Aptorum Group's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-12-11), the Forward Dividend Yield % of Aptorum Group is 0.00%.

Aptorum Group's Dividends per Share for the six months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Aptorum Group Dividend Yield % Historical Data

The historical data trend for Aptorum Group's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Dividend Yield % Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

Get a 7-Day Free Trial

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Yield %	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of Aptorum Group's Dividend Yield %

For the Biotechnology subindustry, Aptorum Group's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptorum Group's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Dividend Yield % falls into.

Aptorum Group Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Aptorum Group (NAS:APM) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Aptorum Group Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.